Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Opportunity details

Agency

National Institutes of Health

Notice type

Federal Grant

Original posted

October 2, 2026

Last updated

November 2, 2026

Notice ID

grant-361050

Summary

The purpose of this notice of funding opportunity (NOFO) is to support multidisciplinary consortia of structural biologists, microbiologists, and associated experts to solve complex biological structures related to the prevention, treatment, and cure of HIV and other infectious diseases. Centers are expected to facilitate new collaborations, leverage shared resources, offer services and resources to the research community, and train the next generation of scientists engaged in structural biology of infectious diseases.

Summary fields are from official SAM.gov or Grants.gov structured data. CaptureIQ does not republish full solicitation or grant text.

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Eligible applicant categories

• Public housing authorities/Indian housing authorities
• Native American tribal governments (Federally recognized)
• Independent school districts
• Native American tribal organizations (other than Federally recognized tribal governments)
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• For profit organizations other than small businesses
• Small businesses
• State governments
• County governments
• City or township governments
• Public and State controlled institutions of higher education
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Private institutions of higher education
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Special district governments

Official Grants.gov eligibility information. Listed categories are not a determination that an organization qualifies.

Funding and program

Assistance Listing

93.310

Funding instrument

Cooperative Agreement

Cost sharing

Not required

Estimated total program funding

33,000,000

Official modification date

October 2, 2026

Estimated total program funding is the government figure for the whole program, not an individual award ceiling. These figures are estimates, not guaranteed funding.

Related Federal Opportunities

• Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)National Institutes of Health · Due Sep 30, 20
• Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)National Institutes of Health · Due 2026-11-10
• Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)National Institutes of Health · Due Jul 10, 20
• NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)National Institutes of Health · Due Sep 03, 20